Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avicanna Inc T.AVCN

Alternate Symbol(s):  AVCNF

Healthcare Cannabis
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis & Wellness Products (RHO Phyto), Pharmaceutical Pipeline and Medical Cannabis Care Platform (MyMedi.ca). RHO Phyto formulary offers a diverse range of proprietary formulations, including... see more

Recent & Breaking News (TSX:AVCN)

Avicanna Reports Q3 2023 Results

GlobeNewswire November 14, 2023

Avicanna Announces Appointment of Paul Fornazzari to Board of Directors

GlobeNewswire November 13, 2023

Avicanna To Hold Third Quarter 2023 Earnings Conference Call

GlobeNewswire November 1, 2023

Avicanna Provides Update on the Successful Launch of MyMedi.ca

GlobeNewswire October 11, 2023

Retirement of Chandra Panchal, PhD from the Board of Directors

GlobeNewswire September 1, 2023

Avicanna Reports Q2 2023 Financial Statement

GlobeNewswire August 15, 2023

Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units

GlobeNewswire August 2, 2023

Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca

GlobeNewswire August 1, 2023

Canadian cannabis stock secures leading brands for medical platform

Trevor Abes  July 28, 2023

Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform

GlobeNewswire July 28, 2023

Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay

GlobeNewswire July 17, 2023

Avicanna Provides Corporate Update and Preliminary Q2 Results

GlobeNewswire June 28, 2023

Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna's Proprietary SEDDS Technology Capsules for Canadian and International markets

GlobeNewswire June 26, 2023

Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids ("CCIC")

GlobeNewswire June 22, 2023

Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant

GlobeNewswire June 13, 2023

Shoppers Drug Mart exits medical cannabis business

Trevor Abes  May 29, 2023

Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna's Acquisition of the Medical Cannabis by Shoppers Business

GlobeNewswire May 29, 2023

Avicanna Announces Results of Annual General and Special Meeting and Provides Corporate Update

GlobeNewswire May 17, 2023

Avicanna Reports Q1 2023 Financial Statement

GlobeNewswire May 16, 2023

Avicanna and Northern Green Canada Execute Master Service Agreement to Operationalize MyMedi.ca

GlobeNewswire May 4, 2023